What is Insulet's expected EPS for Q2 2026?

Analysts expect Insulet (PODD) to report consensus EPS of approximately $1.45 for Q2 2026. Estimates range from $1.36 to $1.55.

What revenue do analysts expect for Insulet in Q2 2026?

The consensus revenue forecast for Insulet (PODD) in Q2 2026 is approximately $787M. Forecasts range from $784M to $791M.

How many analysts cover Insulet?

14 analysts contribute to the Insulet (PODD) Q2 2026 consensus estimate.

Has Insulet beaten earnings estimates recently?

Insulet beat analyst EPS estimates in 1 of the last 1 quarter. Insulet beat revenue estimates in 1 of 1. In the most recent quarter (Q1 2026), Insulet EPS beat by 18.5% and revenue beat by 4.4%.

When does Insulet report Q2 2026 earnings?

Insulet (PODD) is expected to report Q2 2026 earnings on August 5, 2026 before market open.

PODD Q2 2026 earnings estimate

Consensus EPS · Q2 2026

$1.45

Consensus revenue · Q2 2026

$787.5M

Analysts

Expected report

Aug 5, 2026

Before open

Upcoming earnings

Locks in 12 days 13 hours · BMO: Locks 8:00 PM ET previous day

Revenue$787.5M$784M – $791M

EPS$1.45$1.36 – $1.55

What to watch

Analyst ratings: Mixed

Make your prediction

Analyst consensus

Based on estimates from 14 analysts.

Metric	Low	Consensus	High
Revenue	$784M	$787.5M	$791M
EPS	$1.36	$1.45	$1.55
EBITDA	$125.9M	$126.4M	$126.8M
EBIT	$90.7M	$91M	$91.3M
Net income	$71.7M	$102M	$110.8M

Revenue$787.5M
EPS$1.45
EBITDA$126.4M
EBIT$91M
Net income$102M

Historical beat/miss

Actual reported results vs. analyst consensus at the time. Positive = beat, negative = miss.

Period	Rev. actual	Rev. est.	Rev. surprise	EPS actual	EPS est.	EPS surprise
Q1 2026	$761.7M	$729.9M	+4.4%	$1.42	$1.20	+18.5%

Q1 2026+4.4%+18.5%

Estimate revisions

How analyst consensus estimates have changed over the past 90 days.

Collecting data

Revision trends appear once we have collected at least two daily snapshots for this period.

Community vs analysts

See how the TickerLeague crowd's forecast stacks up against Wall Street.

Be the first to predict

No community consensus for Insulet (PODD) Q2 2026 yet. Make a prediction to start the crowd forecast.

Make your prediction

Analyst price target

Based on price targets from 5 analysts.

Low: $180.00
Consensus: $214.43
Median: $213.00
High: $249.00
Current: $158.93
Upside: +34.9%

Upside calculated vs most recent trading price of $158.93.

Analyst ratings

Consensus: Buy — based on 50 analyst ratings.

Buy 35Hold 12Sell 3

24-month trend

Recent analyst actions

Date	Firm	Action	From	To
Jul 13, 2026	Truist Securities	maintain	Buy	Buy
Jul 13, 2026	RBC Capital	maintain	Outperform	Outperform
Jul 10, 2026	Stifel	maintain	Buy	Buy
Jul 8, 2026	Citigroup	maintain	Neutral	Neutral
Jul 6, 2026	Evercore ISI Group	maintain	Outperform	Outperform
Jun 12, 2026	Truist Securities	maintain	Buy	Buy
May 28, 2026	Citigroup	maintain	Neutral	Neutral
May 27, 2026	RBC Capital	maintain	Outperform	Outperform
May 27, 2026	BTIG	maintain	Buy	Buy
May 18, 2026	B of A Securities	maintain	Buy	Buy

Jul 13, 2026Truist SecuritiesBuy
Jul 13, 2026RBC CapitalOutperform
Jul 10, 2026StifelBuy
Jul 8, 2026CitigroupNeutral
Jul 6, 2026Evercore ISI GroupOutperform
Jun 12, 2026Truist SecuritiesBuy
May 28, 2026CitigroupNeutral
May 27, 2026RBC CapitalOutperform
May 27, 2026BTIGBuy
May 18, 2026B of A SecuritiesBuy

Frequently asked questions

Insulet (PODD) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Overview

PODD Overview

Counters

Income Statement

Cash Flow

Capital Return

Buybacks2.45% TTM

How this company returns cash to shareholders — buybacks, dividends, and stock splits.

Forecast & Valuation